Brookdale Senior Living (BKD) Barclays 27th Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Barclays 27th Annual Global Healthcare Conference summary
26 Dec, 2025Company overview and market positioning
Operates approximately 650 senior living communities in 41 states, serving about 58,000 residents, with 70% focused on assisted living and memory care.
94% of revenue is private pay, reducing exposure to Medicare/Medicaid changes.
Known for clinical capabilities and innovative care models, addressing needs of an aging population and loneliness epidemic.
Improved capital structure and strong fourth quarter move-ins provide momentum for continued growth.
Occupancy trends and outlook
Recovered nearly 700 basis points of occupancy over three years, with 2025 guidance reflecting continued improvement.
February saw unprecedented sequential occupancy growth, with year-over-year gains accelerating from 80 to 140 basis points between October and February.
Confident in achieving at least 100 basis points occupancy growth for the full year.
Focus on move-ins, improved attrition rates, and internal marketing effectiveness drive gains.
Financial performance and cost structure
RevPAR is 18% higher and same-store operating income per unit is 8% higher than 2019 levels.
Incremental occupancy above fixed cost thresholds yields significant cash flow benefits.
Internal marketing spend is more efficient and delivers better ROI compared to third-party referrals.
Positive free cash flow expected to improve in 2024 and 2025, with capital focused on associates, communities, and revenue-enhancing CapEx.
Latest events from Brookdale Senior Living
- Operational focus, targeted CapEx, and market-driven M&A support growth amid strong demand.BKD
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Record 2025 EBITDA and occupancy set stage for robust 2026 growth and portfolio streamlining.BKD
Q4 202519 Feb 2026 - Q2 saw 20% Adjusted EBITDA growth, higher occupancy, but a wider net loss on higher costs.BKD
Q2 20241 Feb 2026 - 2026 targets $502–$516M Adjusted EBITDA and 8–9% RevPAR growth, led by operational transformation.BKD
Investor Day 202630 Jan 2026 - Q3 2024 delivered 15% EBITDA growth, higher occupancy, and $610M in acquisitions pending.BKD
Q3 202415 Jan 2026 - Strategic acquisitions, strong occupancy, and HealthPlus expansion drive positive 2025 outlook.BKD
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - 2024 results beat guidance; 2025 targets 11%-15% EBITDA growth and positive cash flow.BKD
Q4 202415 Dec 2025 - Contested director election, performance-based pay, and auditor ratification headline the 2025 proxy.BKD
Proxy Filing1 Dec 2025 - Ortelius seeks to overhaul board leadership to address underperformance and drive value creation.BKD
Proxy Filing1 Dec 2025